戻る
Lexeo Therapeutics Inc (LXEO)価格
LXEO 株価推移チャート
LXEO 収入
Lexeo Therapeutics Inc
$7.39
-1.46%
$-0.11
終値： Jan 16, 16:00:00 GMT-5
$7.3
-1.08%
$-0.08
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$7.5
始値
$7.5
当日レンジ
$7.3 - $7.57
52週レンジ
$1.45 - $10.99
取引高
951.9K
平均取引高
1.4M
1株当たり利益(TTM)
-2.70
配当利回り
--
時価総額
$533.5M
LXEOとは何ですか？
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The company is headquartered in New York City, New York and currently employs 72 full-time employees. The company went IPO on 2023-11-03. Using a stepwise development approach, the Company is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4-associated Alzheimers disease programs. Its pipeline consists of candidates targeting patient populations. Its most advanced cardiovascular product candidate, LX2006 for the treatment of patients with Friedreichs ataxia (FA), cardiomyopathy, is being evaluated in SUNRISE-FA, an ongoing Phase I/II clinical trial. Its second most advanced cardiovascular product candidate, LX2020 for the treatment of arrhythmogenic cardiomyopathy, caused by mutations in the PKP2 gene (PKP2-ACM), received IND clearance from the United States Food and Drug Administration (FDA).